Mark Elliott, MD
Plastic and Reconstructive Surgery · Meridian, MSNPI 1184724718
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 52 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by AbbVie at 37.1% of the total. Reporting peaked in 2022 at $211 and has fallen 68.6% since, to $66 in 2025. That places this record below the midpoint for plastic and reconstructive surgery clinicians in MS, where the typical reported total is $2,915.
Across 52 payments — averaging $16.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$322
- Smith+Nephew$142
- Sientra, Inc.$101
- Organogenesis Inc.$63
- BD$62
- Triad Life Sciences Inc.$48
- plus $130 from 6 others
What the payments were for
- Food & beverage$868100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 18 | $322 |
| Smith+Nephew | 14 | $142 |
| Sientra, Inc. | 4 | $101 |
| Organogenesis Inc. | 4 | $63 |
| BD | 3 | $62 |
| Triad Life Sciences Inc. | 2 | $48 |
| Integra Lifesciences Corporation | 2 | $43 |
| Lilly USA, LLC | 1 | $22 |
| Convatec Inc. | 1 | $21 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
| Galderma Laboratories, L.p. | 1 | $15 |
| Kerecis Limited | 1 | $12 |
How this compares
$868 in reported general payments places this provider in the 15th percentile of 28 plastic and reconstructive surgery providers in Mississippi.
See all plastic and reconstructive surgery providers in Mississippi →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 13 | $180,898 |
| Mupirocin | 19 | $139 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 31 | $107 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $88 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 27 | $68 |
| Ciprofloxacin Hcl | 13 | $51 |
| Tramadol Hcl | 30 | $45 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Meridian
- Lee ThorntonMeridian$14K
- James HendersonMeridian$14
- Frederick SailesMadison$37K
- Gregory GainesTupelo$30K
- John SullivanJackson$12K
- Benjamin McIntyreJackson$11K
- William JacksonMadison$9K
- Michael LebharJackson$8K
- Somjade SongcharoenMadison$7K
- Colton FernstrumJackson$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.